Sylvain LECOMTE – Theradiag

30/03/2022 Evolution of governance

Post author:Sylvain LECOMTE
Post published:30 March 2022
Post category:Press Releases

Presentation of the 2021 full year results (only available in french) – 2022, 21st March

Post author:Sylvain LECOMTE
Post published:21 March 2022
Post category:Financial presentations

24/09/2020: Theradiag opens a new site in Tours

Post author:Sylvain LECOMTE
Post published:24 September 2020
Post category:Press Releases

Croissy-Beaubourg, September 24, 2020, 8:00am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for the French PEA-PME personal equity plan), a company specializing in in vitro diagnostics and theranostics, has opened a new site in…